Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Citrefine International is a specialized biotech and chemical company that develops and supplies Citriodiol, a naturally-sourced active ingredient used in high-performance insect repellents. Derived from the oil of the lemon eucalyptus tree (Eucalyptus citriodora), Citriodiol is globally recognized as the leading natural alternative to synthetic repellents like DEET. The company provides the active ingredient to consumer brands worldwide, supporting them with a comprehensive dossier of safety and efficacy data for regulatory compliance. Their products play a critical role in public health by providing protection against vectors that transmit diseases such as malaria, Zika, and Lyme disease. Citrefine is headquartered in the United Kingdom and maintains a strong focus on sustainable sourcing and rigorous scientific testing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Citrefine International.